NCT07709247

Brief Summary

This study examines saliva samples from patients with osteoporosis. The levels of cytokines and Matrix Metalloproteinase-8 (MMP-8) enzyme in saliva will be measured. Additionally, the dental caries status of participants will be evaluated. The aim of this study is to understand the relationship between osteoporosis and oral health. Only saliva samples will be collected from participants; no treatment or medication will be administered.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
11mo left

Started Jul 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jul 2026Jul 2027

Study Start

First participant enrolled

July 10, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

July 12, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 16, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 10, 2027

Last Updated

July 16, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 12, 2026

Last Update Submit

July 12, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Salivary Cytokine Levels

    Measurement of cytokine levels in saliva samples collected from osteoporosis patients

    day 1

Study Arms (2)

Osteoporosis Group

Patients diagnosed with osteoporosis. Saliva samples will be collected to measure cytokine levels and MMP-8.

Control Group

Healthy individuals without osteoporosis. Saliva samples will be collected for comparison.

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with osteoporosis who applied to the outpatient clinic. Saliva samples and dental caries status will be evaluated. Participants will be selected according to inclusion and exclusion criteria.

You may qualify if:

  • Willing to give voluntary consent For Group 1, having been diagnosed with osteoporosis For Group 2, being systemically healthy and not having a diagnosis of osteoporosis/osteopenia

You may not qualify if:

  • Having a chronic inflammatory or autoimmune disease Using glucocorticoids, anti-anxiety medications, antidepressants, or antiepileptic drugs Having been diagnosed with any malignancy Having any endocrine disease Having undergone periodontal treatment within the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

OsteoporosisDental Caries

Condition Hierarchy (Ancestors)

Bone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesTooth DemineralizationTooth DiseasesStomatognathic Diseases

Central Study Contacts

Kübra Karaçam, Asist.Prof.

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 12, 2026

First Posted

July 16, 2026

Study Start

July 10, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

July 10, 2027

Last Updated

July 16, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share